Vincerx Pharma Common Stock Performance
| VINC Stock | USD 0.01 0.00 0.00% |
The entity has a beta of 2.67, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vincerx Pharma will likely underperform. At this point, Vincerx Pharma Common has a negative expected return of -0.0528%. Please make sure to validate Vincerx Pharma's maximum drawdown, as well as the relationship between the semi variance and rate of daily change , to decide if Vincerx Pharma Common performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Vincerx Pharma Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Vincerx Pharma is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Last Split Factor 1:20 | Last Split Date 2025-01-28 |
1 | iBio vs. Vincerx Pharma Head-To-Head Contrast | 01/22/2026 |
| Begin Period Cash Flow | 12.9 M | |
| Total Cashflows From Investing Activities | 212 K |
Vincerx Pharma Relative Risk vs. Return Landscape
If you would invest 1.44 in Vincerx Pharma Common on November 19, 2025 and sell it today you would lose (0.14) from holding Vincerx Pharma Common or give up 9.72% of portfolio value over 90 days. Vincerx Pharma Common is currently does not generate positive expected returns and assumes 5.0604% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than Vincerx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vincerx Pharma Target Price Odds to finish over Current Price
The tendency of Vincerx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.01 | 90 days | 0.01 | about 50.66 |
Based on a normal probability distribution, the odds of Vincerx Pharma to move above the current price in 90 days from now is about 50.66 (This Vincerx Pharma Common probability density function shows the probability of Vincerx Stock to fall within a particular range of prices over 90 days) .
Vincerx Pharma Price Density |
| Price |
Predictive Modules for Vincerx Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vincerx Pharma Common. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Vincerx Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Vincerx Pharma is not an exception. The market had few large corrections towards the Vincerx Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vincerx Pharma Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vincerx Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.69 | |
β | Beta against Dow Jones | 2.67 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.04 |
Vincerx Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vincerx Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vincerx Pharma Common can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vincerx Pharma generated a negative expected return over the last 90 days | |
| Vincerx Pharma has high historical volatility and very poor performance | |
| Vincerx Pharma has some characteristics of a very speculative penny stock | |
| Vincerx Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.07 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vincerx Pharma Common currently holds about 80.86 M in cash with (26.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from thelincolnianonline.com: iBio vs. Vincerx Pharma Head-To-Head Contrast |
Vincerx Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vincerx Stock often depends not only on the future outlook of the current and potential Vincerx Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vincerx Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.2 M | |
| Cash And Short Term Investments | 5 M |
Vincerx Pharma Fundamentals Growth
Vincerx Stock prices reflect investors' perceptions of the future prospects and financial health of Vincerx Pharma, and Vincerx Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vincerx Stock performance.
| Return On Equity | -31.36 | ||||
| Return On Asset | -1.98 | ||||
| Current Valuation | (4.92 M) | ||||
| Shares Outstanding | 5.23 M | ||||
| Price To Book | 0.03 X | ||||
| EBITDA | (31.46 M) | ||||
| Net Income | (30.07 M) | ||||
| Cash And Equivalents | 80.86 M | ||||
| Cash Per Share | 3.82 X | ||||
| Total Debt | 5.28 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 7.88 X | ||||
| Book Value Per Share | 0.40 X | ||||
| Cash Flow From Operations | (26.13 M) | ||||
| Earnings Per Share | (5.79) X | ||||
| Market Capitalization | 26.17 K | ||||
| Total Asset | 8.01 M | ||||
| Retained Earnings | (189.19 M) | ||||
| Working Capital | 1.13 M | ||||
About Vincerx Pharma Performance
By analyzing Vincerx Pharma's fundamental ratios, stakeholders can gain valuable insights into Vincerx Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Vincerx Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Vincerx Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.32) | (4.10) | |
| Return On Capital Employed | (13.28) | (12.62) | |
| Return On Assets | (4.32) | (4.10) | |
| Return On Equity | (12.70) | (12.06) |
Things to note about Vincerx Pharma Common performance evaluation
Checking the ongoing alerts about Vincerx Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vincerx Pharma Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vincerx Pharma generated a negative expected return over the last 90 days | |
| Vincerx Pharma has high historical volatility and very poor performance | |
| Vincerx Pharma has some characteristics of a very speculative penny stock | |
| Vincerx Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.07 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vincerx Pharma Common currently holds about 80.86 M in cash with (26.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from thelincolnianonline.com: iBio vs. Vincerx Pharma Head-To-Head Contrast |
- Analyzing Vincerx Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vincerx Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Vincerx Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vincerx Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vincerx Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vincerx Pharma's stock. These opinions can provide insight into Vincerx Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Vincerx Stock analysis
When running Vincerx Pharma's price analysis, check to measure Vincerx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vincerx Pharma is operating at the current time. Most of Vincerx Pharma's value examination focuses on studying past and present price action to predict the probability of Vincerx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vincerx Pharma's price. Additionally, you may evaluate how the addition of Vincerx Pharma to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |